Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)-Reference-Cited by-同舟云学术

Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)

Published:2010-02 Issue:2 Volume:159 Page:284-291.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Lee Seung-Whan,Park Seong-Wook,Yun Sung-Cheol,Kim Young-Hak,Park Duk-Woo,Kim Won-Jang,Lee Jong-Young,Lee Cheol Whan,Hong Myeong-Ki,Kim Jae-Joong,Park Seung-Jung

Funder

Cardiovascular Research Foundation, Seoul, Korea,

Korea Health 21 R&D Project, Ministry of Health & Welfare, Korea

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents;Iakovou;JAMA,2005

2. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents;Win;JAMA,2007

3. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA;de la Torre-Hernández;J Am Coll Cardiol,2008

4. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study;Daemen;Lancet,2007

5. Comparison of cilostazol and clopidogrel after successful coronary stenting;Lee;Am J Cardiol,2005

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trial;American Heart Journal;2023-11

2. Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors;Journal of Clinical Medicine;2022-11-21

3. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants after Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06

4. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications;The Journal of Clinical Pharmacology;2021-11-25

5. Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis;Journal of Clinical Medicine;2021-05-29